{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:33:13Z","timestamp":1776832393641,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12264-016-0069-y","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T06:27:23Z","timestamp":1475476043000},"page":"17-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes"],"prefix":"10.1007","volume":"33","author":[{"given":"Feng","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sien","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"69_CR1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0014-4886(03)00246-2","volume":"183","author":"TJ Collier","year":"2003","unstructured":"Collier TJ, Steece-Collier K, Kordower JH. Primate models of Parkinson\u2019s disease. Exp Neurol 2003, 183: 258\u2013262.","journal-title":"Exp Neurol"},{"key":"69_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneumeth.2004.08.004","volume":"139","author":"ME Emborg","year":"2004","unstructured":"Emborg ME. Evaluation of animal models of Parkinson\u2019s disease for neuroprotective strategies. J Neurosci Methods 2004, 139: 121\u2013143.","journal-title":"J Neurosci Methods"},{"key":"69_CR3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ilar.48.4.339","volume":"48","author":"ME Emborg","year":"2007","unstructured":"Emborg ME. Nonhuman primate models of Parkinson\u2019s disease. ILAR J 2007, 48: 339\u2013355.","journal-title":"ILAR J"},{"key":"69_CR4","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(08)60489-4","volume":"371","author":"JP Capitanio","year":"2008","unstructured":"Capitanio JP, Emborg ME. Contributions of non-human primates to neuroscience research. Lancet 2008, 371: 1126\u20131135.","journal-title":"Lancet"},{"issue":"Suppl 4","key":"69_CR5","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1353-8020(09)70829-6","volume":"15","author":"P Jenner","year":"2009","unstructured":"Jenner P. From the MPTP-treated primate to the treatment of motor complications in Parkinson\u2019s disease. Parkinsonism Relat Disord 2009, 15 Suppl 4: S18\u201323.","journal-title":"Parkinsonism Relat Disord"},{"key":"69_CR6","doi-asserted-by":"crossref","first-page":"845618","DOI":"10.1155\/2012\/845618","volume":"2012","author":"J Blesa","year":"2012","unstructured":"Blesa J, Phani S, Jackson-Lewis V, Przedborski S. Classic and new animal models of Parkinson\u2019s disease. J Biomed Biotechnol 2012, 2012: 845618.","journal-title":"J Biomed Biotechnol"},{"key":"69_CR7","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 1983, 80: 4546\u20134550.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"69_CR8","first-page":"548","volume":"20","author":"CC Chiueh","year":"1984","unstructured":"Chiueh CC, Markey SP, Burns RS, Johannessen JN, Jacobowitz DM, Kopin IJ. Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rat, guinea pig, and monkey. Psychopharmacol Bull 1984, 20: 548\u2013553.","journal-title":"Psychopharmacol Bull"},{"key":"69_CR9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","volume":"292","author":"JW Langston","year":"1984","unstructured":"Langston JW, Forno LS, Rebert CS, Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res 1984, 292: 390\u2013394.","journal-title":"Brain Res"},{"key":"69_CR10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(85)90294-X","volume":"335","author":"D Doudet","year":"1985","unstructured":"Doudet D, Gross C, Lebrun-Grandie P, Bioulac B. MPTP primate model of Parkinson\u2019s disease: a mechanographic and electromyographic study. Brain Res 1985, 335: 194\u2013199.","journal-title":"Brain Res"},{"key":"69_CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0304-3940(85)90204-6","volume":"59","author":"W Schultz","year":"1985","unstructured":"Schultz W, Studer A, Jonsson G, Sundstrom E, Mefford I. Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism. Neurosci Lett 1985, 59: 225\u2013232.","journal-title":"Neurosci Lett"},{"key":"69_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0024-3205(86)90431-5","volume":"39","author":"KS Bankiewicz","year":"1986","unstructured":"Bankiewicz KS, Oldfield EH, Chiueh CC, Doppman JL, Jacobowitz DM, Kopin IJ. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 1986, 39: 7\u201316.","journal-title":"Life Sci"},{"key":"69_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00229262","volume":"90","author":"A Benazzouz","year":"1992","unstructured":"Benazzouz A, Gross C, Dupont J, Bioulac B. MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies. Exp Brain Res 1992, 90: 116\u2013120.","journal-title":"Exp Brain Res"},{"key":"69_CR14","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","volume":"21","author":"E Bezard","year":"2001","unstructured":"Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, et al. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson\u2019s disease. J Neurosci 2001, 21: 6853\u20136861.","journal-title":"J Neurosci"},{"key":"69_CR15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0306-4522(86)90102-8","volume":"18","author":"E Eidelberg","year":"1986","unstructured":"Eidelberg E, Brooks BA, Morgan WW, Walden JG, Kokemoor RH. Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys. Neuroscience 1986, 18: 817\u2013822.","journal-title":"Neuroscience"},{"key":"69_CR16","first-page":"11","volume":"20","author":"P Jenner","year":"1986","unstructured":"Jenner P, Marsden CD. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson\u2019s disease. J Neural Transm Suppl 1986, 20: 11\u201339.","journal-title":"J Neural Transm Suppl"},{"key":"69_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0306-4522(89)90212-1","volume":"33","author":"JD Elsworth","year":"1989","unstructured":"Elsworth JD, Deutch AY, Redmond DE, Jr., Taylor JR, Sladek JR, Jr., Roth RH. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions. Neuroscience 1989, 33: 323\u2013331.","journal-title":"Neuroscience"},{"key":"69_CR18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410290618","volume":"29","author":"R Kurlan","year":"1991","unstructured":"Kurlan R, Kim MH, Gash DM. The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys. Ann Neurol 1991, 29: 677\u2013679.","journal-title":"Ann Neurol"},{"key":"69_CR19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0197-4580(95)02012-8","volume":"16","author":"A Ovadia","year":"1995","unstructured":"Ovadia A, Zhang Z, Gash DM. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol Aging 1995, 16: 931\u2013937.","journal-title":"Neurobiol Aging"},{"key":"69_CR20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0306-4522(97)00214-5","volume":"81","author":"JR Taylor","year":"1997","unstructured":"Taylor JR, Elsworth JD, Roth RH, Sladek JR, Jr., Redmond DE, Jr. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience 1997, 81: 745\u2013755.","journal-title":"Neuroscience"},{"key":"69_CR21","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1523\/JNEUROSCI.3465-08.2008","volume":"28","author":"S Boulet","year":"2008","unstructured":"Boulet S, Mounayar S, Poupard A, Bertrand A, Jan C, Pessiglione M, et al. Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis. J Neurosci 2008, 28: 9575\u20139584.","journal-title":"J Neurosci"},{"key":"69_CR22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.expneurol.2008.04.027","volume":"212","author":"F Ding","year":"2008","unstructured":"Ding F, Luan L, Ai Y, Walton A, Gerhardt GA, Gash DM, et al. Development of a stable, early stage unilateral model of Parkinson\u2019s disease in middle-aged rhesus monkeys. Exp Neurol 2008, 212: 431\u2013439.","journal-title":"Exp Neurol"},{"key":"69_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","volume":"184","author":"SH Fox","year":"2010","unstructured":"Fox SH, Brotchie JM. The MPTP-lesioned non-human primate models of Parkinson\u2019s disease. Past, present, and future. Prog Brain Res 2010, 184: 133\u2013157.","journal-title":"Prog Brain Res"},{"key":"69_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.expneurol.2012.02.005","volume":"235","author":"BA Morrow","year":"2012","unstructured":"Morrow BA, Roth RH, Redmond DE, Jr., Diano S, Elsworth JD. Susceptibility to a parkinsonian toxin varies during primate development. Exp Neurol 2012, 235: 273\u2013281.","journal-title":"Exp Neurol"},{"key":"69_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(97)00531-3","volume":"766","author":"E Bezard","year":"1997","unstructured":"Bezard E, Imbert C, Deloire X, Bioulac B, Gross C. A chronic MPTP model reproducing the slow evolution of Parkinson\u2019s disease: evolution of motor symptoms in the monkey. Brain Res 1997, 766: 107\u2013112.","journal-title":"Brain Res"},{"issue":"Suppl 2","key":"69_CR26","first-page":"S111","volume":"64","author":"K Marek","year":"2008","unstructured":"Marek K, Jennings D, Tamagnan G, Seibyl J. Biomarkers for Parkinson\u2019s [corrected] disease: tools to assess Parkinson\u2019s disease onset and progression. Ann Neurol 2008, 64 Suppl 2: S111\u2013121.","journal-title":"Ann Neurol"},{"key":"69_CR27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(97)00531-3","volume":"766","author":"E Bezard","year":"1997","unstructured":"Bezard E, Imbert C, Deloire X, Bioulac B, Gross CE. A chronic MPTP model reproducing the slow evolution of Parkinson\u2019s disease: evolution of motor symptoms in the monkey. Brain Res 1997, 766: 107\u2013112.","journal-title":"Brain Res"},{"key":"69_CR28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, et al. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 2001, 76: 1265\u20131274.","journal-title":"J Neurochem"},{"key":"69_CR29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870060205","volume":"6","author":"R Kurlan","year":"1991","unstructured":"Kurlan R, Kim MH, Gash DM. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism. Mov Disord 1991, 6: 111\u2013118.","journal-title":"Mov Disord"},{"key":"69_CR30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00702-012-0770-6","volume":"119","author":"F Yue","year":"2012","unstructured":"Yue F, Zeng S, Wu D, Yi D, Alex Zhang Y, Chan P. Age-related decline in motor behavior and striatal dopamine transporter in cynomolgus monkeys. J Neural Transm 2012, 119: 943\u2013952.","journal-title":"J Neural Transm"},{"key":"69_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1212\/WNL.41.5_Suppl_2.8","volume":"41","author":"WC Koller","year":"1991","unstructured":"Koller WC, Langston JW, Hubble JP, Irwin I, Zack M, Golbe L, et al. Does a long preclinical period occur in Parkinson\u2019s disease? Neurology 1991, 41: 8\u201313.","journal-title":"Neurology"},{"key":"69_CR32","first-page":"19","volume":"45","author":"O Hornykiewicz","year":"1987","unstructured":"Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson\u2019s disease. Adv Neurol 1987, 45: 19\u201334.","journal-title":"Adv Neurol"},{"issue":"Pt 2","key":"69_CR33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/brain\/119.2.585","volume":"119","author":"PK Morrish","year":"1996","unstructured":"Morrish PK, Sawle GV, Brooks DJ. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson\u2019s disease. Brain 1996, 119 (Pt 2): 585\u2013591.","journal-title":"Brain"},{"key":"69_CR34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0006-8993(92)91201-O","volume":"585","author":"I Perez-Otano","year":"1992","unstructured":"Perez-Otano I, Herrero MT, Luquin MR, Obeso JA, Del Rio J. Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset. Brain Res 1992, 585: 156\u2013160.","journal-title":"Brain Res"},{"key":"69_CR35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00230443","volume":"96","author":"P Gaspar","year":"1993","unstructured":"Gaspar P, Febvret A, Colombo J. Serotonergic sprouting in primate MTP-induced hemiparkinsonism. Exp Brain Res 1993, 96: 100\u2013106.","journal-title":"Exp Brain Res"},{"key":"69_CR36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-4522(99)00437-6","volume":"95","author":"JD Elsworth","year":"2000","unstructured":"Elsworth JD, Taylor JR, Sladek JR, Jr., Collier TJ, Redmond DE, Jr., Roth RH. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience 2000, 95: 399\u2013408.","journal-title":"Neuroscience"},{"key":"69_CR37","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1523\/JNEUROSCI.20-13-05102.2000","volume":"20","author":"DD Song","year":"2000","unstructured":"Song DD, Haber SN. Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J Neurosci 2000, 20: 5102\u20135114.","journal-title":"J Neurosci"},{"key":"69_CR38","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/brain\/awm208","volume":"130","author":"S Mounayar","year":"2007","unstructured":"Mounayar S, Boulet S, Tande D, Jan C, Pessiglione M, Hirsch EC, et al. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain 2007, 130: 2898\u20132914.","journal-title":"Brain"},{"key":"69_CR39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0306-4522(87)90178-3","volume":"23","author":"CM Waters","year":"1987","unstructured":"Waters CM, Hunt SP, Jenner P, Marsden CD. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset. Neuroscience 1987, 23: 1025\u20131039.","journal-title":"Neuroscience"},{"key":"69_CR40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-4522(97)00226-1","volume":"81","author":"E Bezard","year":"1997","unstructured":"Bezard E, Boraud T, Bioulac B, Gross CE. Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism. Neuroscience 1997, 81: 399\u2013404.","journal-title":"Neuroscience"},{"key":"69_CR41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.1977.00500130053010","volume":"34","author":"PL McGeer","year":"1977","unstructured":"McGeer PL, McGeer EG, Suzuki JS. Aging and extrapyramidal function. Arch Neurol 1977, 34: 33\u201335.","journal-title":"Arch Neurol"},{"key":"69_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0197-4580(89)80005-3","volume":"10","author":"GL Wenk","year":"1989","unstructured":"Wenk GL, Pierce DJ, Struble RG, Price DL, Cork LC. Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol Aging 1989, 10: 11\u201319.","journal-title":"Neurobiol Aging"},{"issue":"Suppl","key":"69_CR43","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1002\/ana.410320723","volume":"32","author":"DL Felten","year":"1992","unstructured":"Felten DL, Felten SY, Steece-Collier K, Date I, Clemens JA. Age-related decline in the dopaminergic nigrostriatal system: the oxidative hypothesis and protective strategies. Ann Neurol 1992, 32 Suppl: S133\u2013136.","journal-title":"Ann Neurol"},{"key":"69_CR44","first-page":"251","volume":"3","author":"I Irwin","year":"1994","unstructured":"Irwin I, DeLanney LE, McNeill T, Chan P, Forno LS, Murphy GM, Jr., et al. Aging and the nigrostriatal dopamine system: a non-human primate study. Neurodegeneration 1994, 3: 251\u2013265.","journal-title":"Neurodegeneration"},{"key":"69_CR45","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0197-4580(95)02013-6","volume":"16","author":"GA Gerhardt","year":"1995","unstructured":"Gerhardt GA, Cass WA, Henson M, Zhang Z, Ovadia A, Hoffer BJ, et al. Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey. Neurobiol Aging 1995, 16: 939\u2013946.","journal-title":"Neurobiol Aging"},{"key":"69_CR46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<253::AID-CNE7>3.0.CO;2-X","volume":"401","author":"ME Emborg","year":"1998","unstructured":"Emborg ME, Ma SY, Mufson EJ, Levey AI, Taylor MD, Brown WD, et al. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol 1998, 401: 253\u2013265.","journal-title":"J Comp Neurol"},{"key":"69_CR47","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1111\/j.1460-9568.2008.06307.x","volume":"27","author":"NM Kanaan","year":"2008","unstructured":"Kanaan NM, Kordower JH, Collier TJ. Age-related changes in dopamine transporters and accumulation of 3-nitrotyrosine in rhesus monkey midbrain dopamine neurons: relevance in selective neuronal vulnerability to degeneration. Eur J Neurosci 2008, 27: 3205\u20133215.","journal-title":"Eur J Neurosci"},{"key":"69_CR48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pbb.2011.05.007","volume":"99","author":"P Hurley","year":"2011","unstructured":"Hurley P, Elsworth J, Whittaker M, Roth R, Redmond D. Aged monkeys as a partial model for Parkinson\u2019s disease. Pharmacology Biochemistry and Behavior 2011, 99: 324\u2013332.","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"69_CR49","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.22284","volume":"69","author":"R Fuente-Fernandez de la","year":"2011","unstructured":"de la Fuente-Fernandez R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, et al. Age-specific progression of nigrostriatal dysfunction in Parkinson\u2019s disease. Ann Neurol 2011, 69: 803\u2013810.","journal-title":"Ann Neurol"},{"key":"69_CR50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0006-8993(99)01343-8","volume":"829","author":"AH Andersen","year":"1999","unstructured":"Andersen AH, Zhang Z, Zhang M, Gash DM, Avison MJ. Age-associated changes in rhesus CNS composition identified by MRI. Brain Res 1999, 829: 90\u201398.","journal-title":"Brain Res"},{"key":"69_CR51","first-page":"113","volume":"52","author":"ML Jones","year":"1982","unstructured":"Jones ML. Longevity of captive mammals. Zoologische Garten 1982, 52: 113-128.","journal-title":"Zoologische Garten"},{"key":"69_CR52","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.279.5358.1831h","volume":"279","author":"JM Robine","year":"1998","unstructured":"Robine JM, Allard M. The oldest human. Science 1998, 279: 1834\u20131835.","journal-title":"Science"},{"key":"69_CR53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1385\/MN:28:3:209","volume":"28","author":"W Meissner","year":"2003","unstructured":"Meissner W, Prunier C, Guilloteau D, Chalon S, Gross CE, Bezard E. Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson\u2019s disease. Mol Neurobiol 2003, 28: 209\u2013218.","journal-title":"Mol Neurobiol"},{"key":"69_CR54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12264-013-1374-3","volume":"30","author":"Y Liu","year":"2014","unstructured":"Liu Y,\u00a0Yue\u00a0F,\u00a0Tang R,\u00a0Tao G,\u00a0Pan X,\u00a0Zhu L, et al. Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133). Neurosci Bull 2014, 30: 409\u2013416.","journal-title":"Neurosci Bull"},{"key":"69_CR55","doi-asserted-by":"crossref","unstructured":"Araki T1, Kumagai T, Tanaka K, Matsubara M, Kato H, Itoyama Y, et al. Neuroprotective effect of riluzole in MPTP-treated mice. Brain Res. 2001, 918: 176\u2013181.","DOI":"10.1016\/S0006-8993(01)02944-4"},{"key":"69_CR56","doi-asserted-by":"crossref","unstructured":"Ferro MM1, Angelucci ME, Anselmo-Franci JA, Canteras NS, Da Cunha C. Neuroprotective effect of ketamine\/xylazine on two rat models of Parkinson\u2019s disease. Braz J Med Biol Res 2007, 40: 89\u201396.","DOI":"10.1590\/S0100-879X2007000100012"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-016-0069-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-016-0069-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-016-0069-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T02:16:49Z","timestamp":1568427409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-016-0069-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s12264-016-0069-y","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]}}}